Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
New hope for chronic hive sufferers: Long-Term drug study launches
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of barzolvolimab for adults with chronic spontaneous urticaria (CSU), a condition causing frequent hives and itching. Participants have already completed earlier phase 3 trials and will continue receiving the drug to see …
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 17, 2026 06:17 UTC
-
New drug may stop hives from cold and scratching in their tracks
Disease control Recruiting nowThis study tests a new medicine called barzolvolimab for people who get hives from cold temperatures or from scratching their skin. About 240 adults who still have symptoms despite taking allergy pills will receive either the study drug or a placebo. The goal is to see if the dru…
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New asthma drug trial seeks volunteers for safety check
Symptom relief Recruiting nowThis early-stage study tests a single dose of an experimental drug called CDX-622 in 12 adults with mild to moderate asthma. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure changes in airway inflammation and blood cells. …
Phase: PHASE1 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC